French Electronic Equipment and Components Stock News

ENXTPA:GET
ENXTPA:GETInfrastructure

Getlink (ENXTPA:GET) Posted Strong Half Year Earnings, Is The Premium Valuation Justified?

Why Getlink’s Latest Half Year Earnings Matter For Investors Getlink (ENXTPA:GET) has drawn fresh attention after reporting half year 2026 earnings, with sales and revenue of €824 million and net income of €118 million, compared with the prior year period. See our latest analysis for Getlink. Despite some minor daily fluctuations, Getlink’s share price has a year to date return of 16.53%, while the 1 year total shareholder return of 18.75% reflects recent performance. If Getlink’s results...
ENXTPA:NEX
ENXTPA:NEXElectrical

Why Nexans (ENXTPA:NEX) Is Up 7.1% After Stronger Sales But Weaker Earnings And M&A Push

Nexans S.A. recently reported past half-year 2026 results showing sales rising to €4,736 million from €3,977 million, while net income fell to €103 million from €372 million and earnings per share also decreased versus a year earlier. At the same time, the company confirmed it is actively pursuing mergers and acquisitions as part of its profitable growth plan, underpinned by refreshed board committee roles with high levels of director independence. Now we’ll examine how Nexans’ higher sales...
ENXTPA:VIE
ENXTPA:VIEIntegrated Utilities

Can Veolia Environnement (ENXTPA:VIE) Justify Its Valuation Following Cúcuta Expansion And H1 Results?

Veolia Environnement (ENXTPA:VIE) is in focus after securing a long term water and sanitation contract in Cúcuta, Colombia, alongside reporting half year 2026 results and reaffirming its 2026 dividend guidance. See our latest analysis for Veolia Environnement. At a share price of €34.98, Veolia Environnement has delivered a 16.06% year to date share price return, supported by the Cúcuta contract, half year 2026 earnings and reaffirmed 2026 dividend guidance. Its 1 year total shareholder...
ENXTPA:SAN
ENXTPA:SANPharmaceuticals

Could Sanofi’s (ENXTPA:SAN) Expanded Infant Vaccine Approval Reinforce Its Vaccines-Led Investment Story?

In late July 2026, the European Commission approved Sanofi’s MenQuadfi meningococcal vaccine for use in EU infants from six weeks of age, extending coverage against serogroups A, C, W, and Y and aligning dosing with routine pediatric schedules. This broadened indication gives Sanofi an earlier entry point into infant immunization programs, potentially deepening its vaccines footprint in a high‑need, high‑risk population. Next, we’ll examine how gaining infant approval for MenQuadfi across...
ENXTPA:MEMS
ENXTPA:MEMSSemiconductor

European Market Insights: MEMSCAP And 2 More Noteworthy Penny Stocks

The European stock market has recently experienced a boost, with the pan-European STOXX Europe 600 Index reaching new highs driven by strong corporate earnings and renewed interest in AI-related stocks. For investors willing to explore beyond well-known names, penny stocks—often representing smaller or emerging companies—can present intriguing opportunities. Despite the term's dated connotation, these stocks remain relevant as they can offer surprising value and potential growth when backed...
ENXTPA:STMPA
ENXTPA:STMPASemiconductor

Why STMicroelectronics (ENXTPA:STMPA) Is Up 5.4% After Strong Q2 2026 Beat And Raised H2 Outlook

In July 2026, STMicroelectronics reported second-quarter 2026 results showing year-over-year growth in revenue to US$3,487 million and a swing to net income of US$222 million, while also improving earnings per share from a loss to US$0.24 on a diluted basis. The company also issued guidance for the third and fourth quarters of 2026 pointing to higher revenues and second-half growth above its usual seasonality, signaling management’s confidence in the strength and visibility of current...
ENXTPA:DG
ENXTPA:DGConstruction

Why Vinci (ENXTPA:DG) Is Up 6.7% After Strong H1 2026 Results And Higher Dividend

Vinci SA recently reported past half-year 2026 results showing sales of €36,040 million and net income of €2,078 million, alongside higher earnings per share versus a year earlier. The company also approved a higher interim dividend of €1.10 per share for 2026 and confirmed guidance for further growth in revenue, operating earnings and net income, underlining management’s confidence in its current trajectory. Next, we’ll examine how Vinci’s stronger first-half profitability and increased...
ENXTPA:BVI
ENXTPA:BVIProfessional Services

Bureau Veritas (ENXTPA:BVI) Could Be 11% Undervalued On Mixed H1 Results

Bureau Veritas (ENXTPA:BVI) is in focus after reporting half year 2026 results that show higher sales alongside lower profit, coupled with new Executive Committee appointments that reshape leadership for corporate development, commercial operations, and performance. See our latest analysis for Bureau Veritas. The half year 2026 update has come alongside firm share price momentum for Bureau Veritas, with a 7 day share price return of 4.79% and a 90 day share price return of 6.83%. Over the...
ENXTPA:ERA
ENXTPA:ERAMetals and Mining

3 European Stocks That May Be Undervalued In August 2026

In recent weeks, the European markets have shown resilience, with the pan-European STOXX Europe 600 Index reaching new highs driven by strong corporate earnings and a recovery in sentiment toward AI-related stocks. As investors navigate these evolving conditions, identifying potentially undervalued stocks can be a strategic approach to capitalize on market opportunities.
ENXTPA:LR
ENXTPA:LRElectrical

Is Legrand (ENXTPA:LR) Undervalued After Its Latest Half Year Earnings?

Recent Earnings Spark Fresh Interest In Legrand Stock Legrand (ENXTPA:LR) drew fresh attention after reporting half year 2026 earnings, with sales of €5,400.3m and net income of €698.2m compared with the same period a year earlier. See our latest analysis for Legrand. Legrand’s latest earnings update has come alongside a 1-year total shareholder return of 9.0% and a 3-year total shareholder return of 59.7%, although the 90-day share price return is down 13.71%. This points to fading short...
ENXTPA:CLARI
ENXTPA:CLARIHealthcare

Clariane (ENXTPA:CLARI) Could Be 13% Undervalued Following Strong Half Year Results

Clariane (ENXTPA:CLARI) drew fresh attention after reporting half year 2026 results, highlighting higher operating EBITDA, lower net debt following a €1.063b bond issue, and reaffirmed medium term growth and margin objectives. See our latest analysis for Clariane. Clariane’s recent bond issue and half year 2026 earnings update arrived after a mixed period, with the share price up 3.05% year to date but the 1 year total shareholder return down 7.15%. This points to modest recent momentum while...
ENXTPA:PARRO
ENXTPA:PARROCommunications

Leonardo Stock Leads 3 AI Fire Detection And Drone Plays For Investors

Wildfire risk is pushing governments and emergency services to look harder at AI fire detection, smart sensors, and drone technology, and that shift is starting to influence how investors think about related stocks. The AI Fire Detection and Drone Technology Opportunity Stocks screener focuses on companies directly exposed to this news driven theme, from real time camera analytics to aerial monitoring platforms. This article walks through 3 stocks that could potentially benefit from rising...
ENXTPA:SAF
ENXTPA:SAFAerospace & Defense

Safran (ENXTPA:SAF) Following Raised 2026 Guidance, Is Fair Value Still In Reach?

Why Safran stock is in focus after new guidance and half year results Safran (ENXTPA:SAF) drew fresh attention after its board met on 27 July to review half year 2026 figures and the company raised full year revenue growth guidance despite a drop in net income. The company now expects 2026 revenue growth in the mid teens, with management indicating a target above €36b. This update followed half year 2026 sales of €17,245m and revenue of €17,458m. See our latest analysis for Safran. Safran’s...
ENXTPA:EXA
ENXTPA:EXAAerospace & Defense

Exail Technologies (ENXTPA:EXA) Could Be 18% Undervalued As 2026 Growth Guidance Holds

Why Exail Technologies Stock Is Back in Focus After Fresh 2026 Guidance Exail Technologies (ENXTPA:EXA) confirmed its objective of double digit revenue growth for 2026 and reported second quarter revenue of €144 million alongside first half revenue of €275 million on 23 July 2026. This combination of fresh guidance and updated revenue figures gives you new data to assess how the stock’s current performance and multi year track record might align with your own expectations and risk...
ENXTPA:NK
ENXTPA:NKBasic Materials

Imerys (ENXTPA:NK) Could Be 2% Undervalued As Earnings Slip

Imerys earnings move puts recent share performance under the spotlight Imerys (ENXTPA:NK) just reported half year 2026 earnings that showed €1,740.2 million in sales and €49.4 million in net income, both below the levels reported a year earlier. Basic earnings per share from continuing operations came in at €0.58, with diluted EPS at €0.57, compared with higher figures in the prior period. This earnings profile now sits against a stock that has risen over the past year. See our latest...
ENXTPA:AMUN
ENXTPA:AMUNCapital Markets

Amundi (ENXTPA:AMUN) Following Record Inflows And Earnings, Is The Stock Already Fully Valued?

Amundi (ENXTPA:AMUN) is in focus after its board reviewed first half 2026 accounts and released second quarter results, highlighting record net inflows, higher revenue, and lower net income compared with the prior year period. See our latest analysis for Amundi. The earnings update and record net inflows have come alongside strong momentum in Amundi’s stock, with a 35.67% year to date share price return and a 57.15% 1 year total shareholder return from dividends and price gains combined. If...
ENXTPA:ALO
ENXTPA:ALOMachinery

What Alstom (ENXTPA:ALO)'s New EUR 270 Million X’trapolis 2.0 Order Means For Shareholders

In August 2026, the Victorian Government exercised an option for 25 additional X’trapolis 2.0 trains, awarding Alstom S.A. a EUR 270 million contract that lifts the total fleet under manufacture in Victoria to 50 trains, with the order to be booked in the second quarter of Alstom’s 2026/27 fiscal year. This follow-on order, coming after the first X’trapolis 2.0 entered passenger service in May 2026 to replace a decades-old fleet, underlines recurring demand for Alstom’s latest rolling stock...
ENXTPA:MC
ENXTPA:MCLuxury

LVMH Moët Hennessy Louis Vuitton Société Européenne (ENXTPA:MC) Could Be 8% Below Fair Value After Earnings

LVMH Moët Hennessy - Louis Vuitton Société Européenne (ENXTPA:MC) is in focus after reporting half year 2026 earnings, with sales edging to €38.6b and net income of €5.7b, broadly unchanged year on year. See our latest analysis for LVMH Moët Hennessy - Louis Vuitton Société Européenne. LVMH Moët Hennessy - Louis Vuitton Société Européenne’s latest half year earnings sit against a mixed price backdrop, with the share price up 2.3% over 90 days but down 24.4% year to date, while the 1 year...
ENXTPA:RF
ENXTPA:RFDiversified Financial

Eurazeo (ENXTPA:RF) Stock Rich Valuation Meets Losses And Thin Dividend Cover

Eurazeo stock barely flinched into these H1 2026 results, with the shares at €50.65 after a solid run over the past month. Yet the earnings story is less about the share price and more about the balance sheet. The group still sits on a rich price to sales multiple of 9.3x while reporting losses on a trailing twelve month basis. The real headline is the tension between a high valuation, ongoing losses and a 6.34% dividend yield that is poorly covered by earnings and free cash flow. Like the...
ENXTPA:CRAV
ENXTPA:CRAVBanks

Caisse Régionale De Crédit Agricole Atlantique Vendée (ENXTPA:CRAV) Stock Price Meets Funding Doubts

The market has spent the past three months marking Caisse régionale de Crédit Agricole Mutuel Atlantique Vendée down, with the stock now about 12% lower even after closing at €138. Yet the latest half year numbers tell a more complicated story. Earnings over the last 12 months reached €105.3 million and the net profit margin sits at 23.1%. The stock trades on a P/E of 9.7x, which leaves you weighing a cheaper valuation against a bank that still carries 65% of its liabilities in higher risk...
ENXTPA:AKE
ENXTPA:AKEChemicals

Arkema (ENXTPA:AKE) Following Softer Half Year Earnings Still Looks Near Fair Value

Why Arkema’s Latest Half Year Earnings Matter For Investors Arkema (ENXTPA:AKE) reported half year 2026 results with sales of €4,609.6 million and net income of €92.9 million, both lower than a year earlier. Earnings per share also declined over the period. See our latest analysis for Arkema. Arkema’s latest half year earnings came alongside a 1 month share price return of 8.04% and a year to date share price return of 16.81%, although the 3 year total shareholder return declined 26.02%...
ENXTPA:RBT
ENXTPA:RBTChemicals

Robertet (ENXTPA:RBT) Could Be 20% Below Fair Value After Its H1 Revenue Update

Robertet revenue update and what it could mean for investors Robertet (ENXTPA:RBT) reported unaudited first half 2026 revenue of €444.281 million, slightly below the €446.337 million posted a year earlier. Management highlighted euro appreciation and consolidation scope changes as key headwinds. See our latest analysis for Robertet. At a share price of €802.0, Robertet has seen its short term momentum soften, with a 7 day share price return down 2.43% and year to date share price return down...